Quick Answer
Ashwagandha Fatigue Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Although its safety at conventional doses is well established, evidence regarding the safety of higher doses in healthy adults remains limited.
Key Takeaways
- 01Although its safety at conventional doses is well established, evidence regarding the safety of higher doses in healthy adults remains limited. [Movva N (2026)]
- 02All values remained within reference ranges and were clinically insignificant, with most values slightly reduced except a small increase in alkaline phosphatase. [Movva N (2026)]
- 03Quality of life (SF-36 scores) demonstrated improvement ( p Conclusion High-dose Ashwagandha root extract (2000 mg/day) was well tolerated and demonstrated a favourable safety profile in healthy adults over 12 weeks. [Movva N (2026)]
- 04Background and aim Ashwagandha, adaptogenic herb traditionally used to enhance resilience to stress and promote overall well-being. [Movva N (2026)]
The current Migaku evidence database contains 1 reusable source document for Ashwagandha Fatigue Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Although its safety at conventional doses is well established, evidence regarding the safety of higher doses in healthy adults remains limited. [Movva N (2026); evidence level 4]
- All values remained within reference ranges and were clinically insignificant, with most values slightly reduced except a small increase in alkaline phosphatase. [Movva N (2026); evidence level 4]
- Quality of life (SF-36 scores) demonstrated improvement ( p Conclusion High-dose Ashwagandha root extract (2000 mg/day) was well tolerated and demonstrated a favourable safety profile in healthy adults over 12 weeks. [Movva N (2026); evidence level 4]
- Background and aim Ashwagandha, adaptogenic herb traditionally used to enhance resilience to stress and promote overall well-being. [Movva N (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources